Welcome to our dedicated page for CAMTEK SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CAMTEK's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CAMTEK's regulatory disclosures and financial reporting.
CAMTEK LTD director Andorn Karni Yarl reported option exercises and share sales in August 2026. On August 14, stock options for 3,176 Ordinary Shares at an exercise price of $22.63 per share were exercised and the resulting shares were sold at $164.40 per share. On August 13, options for 880 shares at $63.51 were exercised and the resulting shares were sold in multiple transactions, including 880 shares at $172.7428 and 1,476 shares at a weighted average price of $172.1221 per share, with detailed price ranges disclosed in a footnote. The options and underlying shares referenced in certain transactions were exercised and sold on the same dates.
Camtek Ltd (CAMT) Chief Operating Officer Ram Langer reported a sale of 6,387 Ordinary Shares on 2026-08-13 in an open-market or private transaction. The shares were sold at a weighted average price of $172.3222 per share, with individual trade prices ranging from $172.13 to $172.72. Following this transaction, Langer directly holds 17,532 Ordinary Shares. The transaction was not reported as made under a Rule 10b5-1 trading plan.
CAMTEK LTD Chief Executive Officer Rafi Amit reported selling 6,250 Ordinary Shares of CAMT on 2026-08-13 in a sale classified as an open market or private transaction at a price of $170.52 per share. Following this transaction, he directly holds 55,350 Ordinary Shares. The sale was not marked as being made under a Rule 10b5-1 trading plan.
Camtek Ltd. investor Yael Andorn filed a Form 144 notice for a proposed sale of 3,176 ordinary shares of Camtek Ltd., to be handled through Oppenheimer & Co. Inc. on or after 08/14/2026 on Nasdaq. The shares are described as having been acquired upon the exercise of employee stock options, with a cash payment made upon exercise of those options.
The filing also lists securities sold during the past three months, showing that on 08/13/2026 Andorn sold 2,356 ordinary shares for an aggregate amount of 406,065.92. The Form 144 serves as an advance notice of the potential future sale of restricted or control shares.
Camtek Ltd. filed a notice of proposed sale of 6,250 Ordinary Shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $1,088,750.00, based on 45,828,133 Ordinary Shares outstanding as of the notice. The filing also lists prior issuances of Ordinary Shares upon vesting of RSUs on 01/24/2023 (15,145 shares), 02/16/2023 (10,097 shares), and 01/16/2024 (19,878 shares), all issued for no cash consideration.
Camtek Ltd has a notice to sell 2,356 Ordinary Shares on Nasdaq through Oppenheimer & Co. Inc., with the entry dated 08/13/2026. The shares to be sold were acquired from equity compensation: 1,082 shares issued upon vesting of RSUs on 12/21/2023, 394 shares issued upon vesting of RSUs on 09/25/2024, and 880 shares acquired upon exercise of employee stock options on 08/13/2026. The RSU shares were received for no cash consideration, while the option shares required a cash payment upon exercise.
A shareholder of Camtek Ltd. filed to potentially sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, on or after August 13, 2026 through Oppenheimer & Co. Inc. on Nasdaq. The filing also lists prior Ordinary Shares issued upon vesting of RSUs on January 16, 2024 (12,701 shares) and April 1, 2025 (2,872 and 1,701 shares) for no cash consideration.
CAMTEK LTD vice president of HR, Orit Geva-Dvash, reported a sale of 415 Ordinary Shares of CAMT on 2026-08-12 at $174.0623 per share in an open-market or private transaction. Following this sale, she directly holds 5,713 Ordinary Shares, a balance that includes one additional share previously omitted from her Form 3 due to a rounding error. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.
Camtek Ltd (CAMT) director Aviram Lior reported selling a total of 6,694 ordinary shares in four open-market transactions on August 11–12, 2026, at prices between 162.0000 and 175.0000 per share. The Rule 10b5-1 checkbox was not selected. A footnote explains that one additional share had been omitted from a prior Form 3 due to a rounding error.
Camtek Ltd. Chief Financial Officer Moshe Eisenberg reported open-market sales of Camtek ordinary shares. On 2026-08-12 he sold 645 shares at $172.6717 per share. On 2026-08-11 he sold 3,759 shares at a weighted average price of $160.0561, in multiple trades between $160.00 and $160.5651 per share.